Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.85
Bid: 0.80
Ask: 0.90
Change: 0.025 (3.03%)
Spread: 0.10 (12.50%)
Open: 0.85
High: 0.85
Low: 0.85
Prev. Close: 0.825
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Zotefoams Hails Record Third Quarter Sales

Thu, 05th Nov 2020 18:07

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Zotefoams PLC - closed-cell crosslinked polyolefin foams manufacturer - Reports "record" third quarter sales performance, with revenue 22% ahead of a year ago. This reflects "very strong" contributions from both personal protective equipment and footwear products. "While the large PPE programme runs down through the latter part of 2020, the strong momentum in footwear and T-FIT insulation products, together with early indications of demand recovery in a number of our markets, supports the board's continued expectation of strong year-on-year sales growth in Q4," Zotefoams says. Expects full-year revenue and underlying pretax profit in line with market expectations.

----------

IQ-AI Ltd - medical software company with headquarters in Jersey - Subsidiary Imaging Biometrics LLC says the Montgomery Cancer Center in the US has purchased IB Clinic. The installation of IB Clinic includes the IB Neuro and IB Delta T1 mapping algorithms. "The Montgomery Cancer Center, one of the largest freestanding centers in the USA, will now be able to automatically generate quantitative parameters using IB's standardised brain tumour imaging protocol for the benefit of patients," says IQ-AI.

----------

Gunsynd PLC - London-based investment firm - Invests further AUD100,000, around GBP54,700, in Australian gold and base metals exploration company Rincon Resources Pty Ltd via a convertible loan. Rincon has lodged a prospectus with Australian Securities & Investments Commission for an initial public offering to raise a minimum of AUD5 million, targeted for early December. "Gunsynd is pleased to continue to add to its existing investment in Rincon Resources. Rincon has what we believe to be a very exciting portfolio of copper/gold projects - particularly the South Telfer project in the Paterson region of Western Australia," says Director Peter Ruse.

----------

Feedback PLC - London-based medical imaging technology company - Reports "busy" start to current year, and says focus is on further growing Bleepa's market base and creating a "strong platform" for revenue growth. Cash position remains strong at GBP4.4 million on September 30, with company fully funded to execute its growth strategy for the current financial year "and beyond". "The board is confident in its ability to deliver on the planned growth, with increased routes to market expected to create strong future revenue streams," Feedback says.

----------

PCI-PAL PLC - secure payment solutions provider - Says first quarter revenue 44% ahead of the same period a year ago, with revenue visibility against current market forecasts for the year ending June 30 now at 88%. "We have been very pleased with the progress that the business has made at the start of this new financial year as we continue to close the gap towards our first months of cash generation and profitability. We look forward to delivering another year of substantial revenue growth and continued execution against our current plan," says PCI-PAL.

----------

N4 Pharma PLC - London-headquartered pharmaceutical company developing Nuvec vaccine and cancer treatment delivery system - Says optimisation work is "progressing well", and company has successfully developed different options to make a fully monodispersed formulation of Nuvec loaded with plasmid DNA. Adds that the plan for the unoptimised Nuvec in vivo study to compare the reactions of Nuvec loaded with the coronavirus plasmid and another generic plasmid in generating relevant antibodies has now been finalised and the study will commence shortly. "Taken together with the work into oral applications and the ongoing technology transfer for the manufacture of Nuvec, we are entering a pivotal time for the company over the next six months and I look forward to providing further updates as each work stream progresses," says Chief Executive Nigel Theobald.

----------

Nostra Terra Oil & Gas Co PLC - AIM-listed company focused on the prolific Permian Basin in West Texas - Cypress Minerals LLC receives drilling permit in preparation to drill the new well at the company's Pine Mills oil field, US. Drilling is permitted to a total depth of 6,000 feet and is estimated to take around 10 days. The primary target formation is the prolific Woodbine Sand, and the well will also evaluate other known overburden formations.

----------

GCP Student Living PLC - UK-focused student accommodation provider - EPRA net asset value per share 171.71 pence at September 30, representing quarterly decrease of 0.07p. At 30 September, the valuation of the company's portfolio was GBP1.01 billion, representing a like-for-like increase over the quarter of 0.7%. "The company's rental income for the financial year ended 30 June 2021 is being materially adversely impacted as a result of the disruption caused by the Covid-19 pandemic. Noting this impact on the company's revenues, the ongoing uncertainties relating to the Covid-19 pandemic and a desire to manage the business in a prudent and conservative manner, the directors have decided to announce a first interim dividend of 0.25 pence," says GCP.

----------

Hansard Global PLC - financial services business operating out of the Isle of Man - Says new business for the quarter to September 30 was GBP34.2 million in present value of new business premiums terms, down 4.5% on a year ago. Assets under administration GBP1.1 billion, up 1.8% from June 30. "While we are confident our new business will continue to be resilient in the face of Covid-19 challenges, we expect it to continue to lag behind the levels achieved last year," says Chief Executive Gordon Marr.

----------

DWF Group PLC - Manchester-based law firm - Says revenue growth in year-to-date "more than" 14%, as activity levels improve to pre-pandemic levels. Says underlying adjusted pretax profit "close to" the GBP13.8 million achieved in the full 2020 financial year. "We have seen a very pleasing recovery in activity levels since the dip caused by COVID-19 in Q4 of FY20. We have prioritised organic growth, acquisition integration and operational efficiency and this focus, combined with our cost reduction measures, has delivered strong profit improvement for the group," says Chief Executive Nigel Knowles. Firm "cautiously optimistic" on the second half.

----------

Anglo Pacific Group PLC - natural resources royalties business based in London - Says total portfolio contribution GBP6.4 million in the third quarter a slight dip from GBP6.5 million in the second quarter. Decrease largely driven by lower volumes at Kestrel following a longwall changeout, which is not expected to reoccur until the third quarter of 2021. Production is expected to increase at Kestrel in the fourth quarter after a record longwall change-out. "We were encouraged by the operating performance of the royalty portfolio during Q3 2020 which continue to function without material Covid-19 disruption. The actions taken by the underlying operators suggests that we could see a stronger finish to the year across the portfolio at a time when certain commodity prices are showing signs of improvement," says Chief Executive Julian Treger.

----------

Jardine Matheson Holdings Ltd - Hong Kong-headquartered holding company with interests in retail, property, hotels and motor dealerships - Continued to face "challenging trading conditions" in third quarter due to Covid-19, though notes "some improvement" in performance across many of its businesses compared to the second quarter. Underlying net profit declined year-on-year in the third quarter, and performance is expected to "remain weak" for the remainder of the year. "The group is, nonetheless, resilient and well-positioned to achieve its long-term growth objectives, and its balance sheet and liquidity position remain strong," says Jardine.

----------

Triple Point Social Housing REIT PLC - London-based real estate investment trust - Says net asset value at September 30 106.12p per share, up 0.7% from June 30. "The group's ongoing receipt of rents remains timely, unaffected by Covid-19, and in line with expectations and prior year experience. As such 100% of rent due for Q3 2020 has been received," says Triple Point.

----------

Argo Blockchain PLC - UK-based cryptocurrency miner - Mines 126 Bitcoin or Bitcoin Equivalent in October, broadly flat on 127 Bitcoin Equivalent in September. Mining revenue in October amounted to GBP1.2 million, versus GBP1.1 in September. Separately says it has entered into an equipment lease with Celsius Network for 4,500 Bitmain Antminer S19 and S19 pro miners for a two year term. The new mining hardware is expected to be fully operational by February 2021. Also says the machines will be hosted by Core Scientific. "We are delighted to partner with Celsius and Core Scientific as we pursue our growth plans. These agreements allow us to secure very competitive terms on both new mining equipment and hosting costs. Argo continues to successfully expand its mining capacity while simultaneously improving mining margins and is in a strong position to benefit from the amelioration in market conditions," says Argo Chief Executive Peter Wall.

----------

UK Oil & Gas PLC - oil and gas exploration company - Says surface-based intervention operations at its 85.6% owned Horse Hill-1 well have now been completed. Well has been shut in for a long term pressure build up test. Alba Mineral Resources PLC holds an 11.8% interest in the Horse Hill oil project, comprising licences PEDL137 and PEDL246.

----------

H&T Group PLC - Surrey, England-based pawnbroker - Says operations fully remain open for business, providing a full range of 'essential' financial services. The 253-strong store estate will remain open for customers during the November lockdown period. Pawnbroking customers continue to repay their loans and at normal pledge redemption rates, says H&T. Adds that retail sales have been strong, and the high gold price has also driven increased gross profit from both pawnbroking and gold purchasing activities. "These strong performances have more than offset weakness in the Group's foreign currency business as a result of reduced international leisure travel," says H&T.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
Today 12:14

N4 Pharma sees potential in Nuvec delivery method for cancer treatment

(Alliance News) - N4 Pharma PLC on Thursday reported that its novel delivery system for cancer treatment has shown promise, after a successful trial.

Read more
15 Feb 2024 13:17

N4 Pharma shares jump on latest Nuvec developments

(Sharecast News) - N4 Pharma announced a significant advancement in the development of Nuvec, an innovative delivery system tailored for cancer treatments, gene therapy, and vaccines, on Thursday.

Read more
15 Feb 2024 12:06

IN BRIEF: N4 Pharma shares rise on "encouraging" Nuvec research

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company, focused on the development of Nuvec - Reports an "encouraging" update from its Nuvec delivery system for cancer treatments, gene therapy and vaccines. It has completed in-vitro experiments combining epidermal growth factor receptor and polo like kinase 1 molecules onto a Nuvec nanoparticle, before testing it on lung cancer cells. "The work clearly shows that there is a strong beneficial effect at 48 hours on cellular inhibition compared to single dose siRNA, by combining both EGFR and PLK1 onto the same particle," N4 says.

Read more
15 Feb 2024 10:52

AIM WINNERS & LOSERS: DSW warns on earnings amid tepid M&A markets

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
19 Jan 2024 13:00

N4 Pharma's Nuvec granted patent in India

(Sharecast News) - N4 Pharma, a pharmaceutical company developing the cancer vaccine delivery system Nuvec, announced on Friday that it has received confirmation from the University of Queensland regarding the granting of its patent for Nuvec in India.

Read more
19 Jan 2024 09:26

IN BRIEF: N4 Pharma gets India patent for medical delivery system

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company, focused on the development of Nuvec - University of Queensland has informed the company that it has been notified by its Indian patent attorney of the granting of its patent for Nuvec in India. Nuvec is a novel silica nanoparticle delivery system for cancer treatments, gene therapy and vaccines. N4 Pharma says the granted patent in India is for a composition of matter patent for the particle itself, alongside the manufacturing process relating to how the particle is made. Says it matches the patents granted in the US, Canada, Europe, Japan, Australia and China.

Read more
16 Jan 2024 14:05

N4 Pharma subsidiary agrees work programme for glaucoma treatment

(Sharecast News) - N4 Pharma announced a significant development through its subsidiary Nanogenics on Tuesday, after Nanogenics inked a contract to initiate the formulation and sequence selection work for its ECP105 product, aimed at pre-clinical studies at King's College, London.

Read more
16 Jan 2024 13:26

IN BRIEF: N4 Pharma touts contract to test glaucoma treatment, ECP105

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company, focused on the development of Nuvec, a novel silica nanoparticle delivery system, for vaccines and therapeutics - Says subsidiary, Nanogenics Ltd, has signed a contract to start the formulation and sequence selection work to prepare its ECP105 product for testing in pre-clinical studies at King's College, London.

Read more
8 Jan 2024 12:30

N4 Pharma reports progress in Nuvec clinical research

(Sharecast News) - Pharmaceutical delivery system developer N4 Pharma reported significant progress in its research efforts to enhance viral vector performance using Nuvec on Monday.

Read more
8 Jan 2024 09:11

N4 Pharma hails increased efficacy of Nuvec when complexed with AAV8

(Alliance News) - N4 Pharma PLC on Monday said that a series of experiments have shown that Nuvec can deliver increased transduction efficacy, when complexed with Adeno-Associated virus 8.

Read more
18 Dec 2023 16:55

LONDON MARKET CLOSE: FTSE 100 outperforms European peers

(Alliance News) - Stock prices in London closed higher on Monday, after investors shrugged off hawkish comments from US Federal Reserve officials amid festive cheer.

Read more
18 Dec 2023 12:43

N4 Pharma rises on successful results from Nuvec administration

(Alliance News) - N4 Pharma PLC on Monday announced the successful oral administration of Nuvec with a DNA plasmid after receiving promising results from its research programme with the University of Queensland.

Read more
18 Dec 2023 11:17

N4 Pharma upbeat on recent Nuvec developments

(Sharecast News) - N4 Pharma updated the market on Monday on its ongoing research efforts related to Nuvec, its delivery system designed for cancer treatments and vaccines.

Read more
7 Dec 2023 18:28

TRADING UPDATES: N4 Pharma hails "encouraging" siRNA research

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
7 Dec 2023 13:20

N4 Pharma posts optimistic Nuvec research update

(Sharecast News) - N4 Pharma, a specialist pharmaceutical company focused on developing the Nuvec delivery system for cancer treatments and vaccines, issued an optimistic update on its ongoing in-vitro siRNA research efforts on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.